ANDE Stock
Rapid DNA Analysis Solutions
Sign up today and learn more about ANDE Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About ANDE Stock
ANDE is dedicated to the development and commercialization of Rapid DNA products for human forensic identification, biothreat detection, and clinical diagnostics. The company believes that moving DNA analysis from the laboratory to the field will dramatically improve societal safety and health. By reducing crime, exonerating the innocent, monitoring borders, and reuniting families, Rapid DNA represents a fundamental opportunity for the public and private sectors to protect the innocent.
Funding History
November 2016 | $16.9M |
---|---|
June 2018 | $25.5M |
Management
Founder & Chairman, Board of Directors
Dr. Richard Selden
Chief Scientific Officer
Dr. Richard Selden
Press
24-7pressrelease - Feb, 6 2024
NEW YEAR, NEW STORE! HANDEL'S HOMEMADE ICE CREAM CELEBRATES STEVENSON RANCH OPENINGaithority - Mar, 10 2022
ANDE Introduces Next Generation Hydrocarbon Testing Solutioneconomictimes - Sep, 30 2021
Viacom18 names Jyoti Deshpande as CEOprnewswire - Jul, 21 2021
Sridhar Ande Joins Payactiv as CFOtechinafrica - Jun, 4 2021
Startup Savanna launches collaborative effort to support Kenyan startups